BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31665635)

  • 21. Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.
    An Y; Adams JR; Hollern DP; Zhao A; Chang SG; Gams MS; Chung PED; He X; Jangra R; Shah JS; Yang J; Beck LA; Raghuram N; Kozma KJ; Loch AJ; Wang W; Fan C; Done SJ; Zacksenhaus E; Guidos CJ; Perou CM; Egan SE
    Cell Rep; 2018 Oct; 25(3):702-714.e6. PubMed ID: 30332649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
    Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
    Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
    Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
    Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
    Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS
    Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
    Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
    Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
    Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
    Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
    Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
    Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase.
    Buijs JT; Matula KM; Cheung H; Kruithof-de Julio M; van der Mark MH; Snoeks TJ; Cohen R; Corver WE; Mohammad KS; Jonkers J; Guise TA; van der Pluijm G
    J Pathol; 2015 Apr; 235(5):745-59. PubMed ID: 25421310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic Plasticity of Fibroblasts during Mammary Carcinoma Development.
    Elwakeel E; Brüggemann M; Fink AF; Schulz MH; Schmid T; Savai R; Brüne B; Zarnack K; Weigert A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505876
    [No Abstract]   [Full Text] [Related]  

  • 32. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression.
    Galmbacher K; Heisig M; Hotz C; Wischhusen J; Galmiche A; Bergmann B; Gentschev I; Goebel W; Rapp UR; Fensterle J
    PLoS One; 2010 Mar; 5(3):e9572. PubMed ID: 20221397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
    Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
    BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.
    Kuwahara K; Yamamoto-Ibusuki M; Zhang Z; Phimsen S; Gondo N; Yamashita H; Takeo T; Nakagata N; Yamashita D; Fukushima Y; Yamamoto Y; Iwata H; Saya H; Kondo E; Matsuo K; Takeya M; Iwase H; Sakaguchi N
    Cancer Sci; 2016 Apr; 107(4):469-77. PubMed ID: 26749495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor macrophages are pivotal constructors of tumor collagenous matrix.
    Afik R; Zigmond E; Vugman M; Klepfish M; Shimshoni E; Pasmanik-Chor M; Shenoy A; Bassat E; Halpern Z; Geiger T; Sagi I; Varol C
    J Exp Med; 2016 Oct; 213(11):2315-2331. PubMed ID: 27697834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization.
    Vallerand D; Massonnet G; Kébir F; Gentien D; Maciorowski Z; De la Grange P; Sigal-Zafrani B; Richardson M; Humbert S; Thuleau A; Assayag F; de Plater L; Nicolas A; Scholl S; Marangoni E; Weigand S; Roman-Roman S; Savina A; Decaudin D
    PLoS One; 2016; 11(7):e0157670. PubMed ID: 27388901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
    Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
    Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes.
    Nguyen DH; Fredlund E; Zhao W; Perou CM; Balmain A; Mao JH; Barcellos-Hoff MH
    Clin Cancer Res; 2013 Mar; 19(6):1353-62. PubMed ID: 23339125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.